Bank of America’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.3M Buy
2,221,289
+547,835
+33% +$14M ﹤0.01% 1569
2025
Q4
$48.6M Buy
1,673,454
+784,169
+88% +$20.1M ﹤0.01% 1584
2025
Q3
$16.8M Sell
889,285
-313,228
-26% -$4.94M ﹤0.01% 2782
2025
Q2
$16.9M Buy
1,202,513
+687,562
+134% +$9.64M ﹤0.01% 2729
2025
Q1
$8.05M Sell
514,951
-21,507
-4% -$303K ﹤0.01% 3358
2024
Q4
$7.47M Sell
536,458
-639,447
-54% -$7.01M ﹤0.01% 3213
2024
Q3
$10.9M Buy
1,175,905
+608,782
+107% +$6.01M ﹤0.01% 2982
2024
Q2
$5.27M Sell
567,123
-283,406
-33% -$2.56M ﹤0.01% 3572
2024
Q1
$8.43M Buy
850,529
+759,511
+834% +$5.67M ﹤0.01% 3144
2023
Q4
$294K Sell
91,018
-259,945
-74% -$707K ﹤0.01% 5846
2023
Q3
$1.86M Sell
350,963
-55,592
-14% -$473K ﹤0.01% 4316
2023
Q2
$3.87M Sell
406,555
-1,215,219
-75% -$13.5M ﹤0.01% 3638
2023
Q1
$17.8M Buy
1,621,774
+1,382,736
+578% +$20M ﹤0.01% 2233
2022
Q4
$3.54M Buy
239,038
+87,781
+58% +$1.53M ﹤0.01% 3732
2022
Q3
$2.89M Buy
151,257
+112,962
+295% +$2.56M ﹤0.01% 3937
2022
Q2
$816K Buy
38,295
+28,295
+283% +$580K ﹤0.01% 5077
2022
Q1
$193K Sell
10,000
-2,110
-17% -$35.7K ﹤0.01% 6488
2021
Q4
$251K Buy
12,110
+5,600
+86% +$111K ﹤0.01% 6358
2021
Q3
$156K Sell
6,510
-23
-0.4% -$525 ﹤0.01% 6460
2021
Q2
$178K Sell
6,533
-23,828
-78% -$671K ﹤0.01% 6166
2021
Q1
$878K Buy
30,361
+25,356
+507% +$792K ﹤0.01% 4944
2020
Q4
$141K Buy
5,005
+486
+11% +$11.9K ﹤0.01% 5814
2020
Q3
$132K Buy
4,519
+743
+20% +$19.9K ﹤0.01% 5528
2020
Q2
$114K Sell
3,776
-896
-19% -$25.9K ﹤0.01% 5607
2020
Q1
$139K Buy
+4,672
New +$126K ﹤0.01% 5321

Other funds holding ARQT